Several large clinical trials have demonstrated that a daily oral dose of one or two antiretroviral drugs used to treat HIV infection can prevent infection in an approach known as pre-exposure prophylaxis, or PrEP. The level ...
not rated yet |
0
(HealthDay)—Using subcutaneously administered ketamine in a dose-escalating regimen as an adjunct to opioids and standard co-analgesics does not have any clinical benefit in relieving cancer pain, but it ...
not rated yet |
0
Dengue is one of the most widespread mosquito-borne viral diseases in the world, with WHO estimating that around half of the world's population are currently at risk. While infection usually causes flu-like symptoms, it can ...
5 / 5 (1) |
0
With the discovery that the unconscious mind plays a key role in the placebo effect, researchers have identified a novel mechanism that helps explain the power of placebos and nocebos.
5 / 5 (4) |
1
Presented last week at the British Science Festival, a new study by University of Aberdeen scientists will examine if the consumption of fish oil combined with weight training exercises could help protect ...
3.3 / 5 (3) |
0
Antibiotic treatment with amoxicillin/clavulanate improves moderate exacerbations in patients with mild-to-moderate chronic obstructive pulmonary disease (COPD) and significantly prolongs the time between exacerbations, according ...
5 / 5 (1) |
1
Ginkgo biloba extract does not significantly reduce the likelihood of diagnosis of Alzheimer's disease in older people, according to the results of the largest ever Alzheimer's prevention study in Europe, published in Lancet Ne ...
not rated yet |
0
|
Taking vitamin D supplements to compensate for vitamin D deficiency didn't improve cholesterol—at least in the short term, according to new research in Arteriosclerosis, Thrombosis and Vascular Biology, an American Heart ...
not rated yet |
0
|
Researchers at Emory University have found that a medication that inhibits inflammation may offer new hope for people with difficult-to-treat depression. The study was published Sept. 3 in the online version of Archives of ...
4.9 / 5 (18) |
3
|
(HealthDay)—The U.S. Food and Drug Administration has approved the drug tbo-filgrastim to treat certain cancer patients undergoing chemotherapy who have a condition called severe neutropenia, the FDA said in a news release.
not rated yet |
0
Fampridine (trade name Fampyra) has been approved in Germany since July 2011 for adult patients suffering from a higher grade walking disability (grades 4 to 7 on the EDSS disability status scale), as a result of multiple ...
not rated yet |
0
New research published Online First in the Lancet is the first to show that gabapentin, a drug widely used to treat pain and seizures, substantially reduces the frequency and severity of coughing and other symptoms associ ...
not rated yet |
0
A new drug treatment could offer hope to patients with advanced colorectal cancer who were intolerant of or did not respond to standard treatments, according to an article published in the Lancet Oncology.
not rated yet |
0
Preliminary results from the Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE) do not support administration of aliskiren on top of standard therapy with renin-angiotensin-aldosterone system (RAAS) ...
not rated yet |
0
(HealthDay)—For patients with chronic liver disease who require an invasive procedure as part of their routine care, the oral thrombopoietin-receptor agonist eltrombopag reduces the need for platelet transfusions, ...
not rated yet |
0
|
